IL17A and psoriasis: The excellent therapeutic efficacy of anti-TNF-α/IL-23/IL-17A biologics for psoriasis point to the central role of the TNF-α/IL-23/IL-17A axis in its pathogenesis [18,19,130,131,132,133,134] Additionally, genetic and environmental factors are known to be involved in its pathogenesis [135,136].